E3	Condition:T3 Name:T4
E6	Condition:T6 Name:T7
E8	Condition:T8 Name:T9
E12	Condition:T12 Name:T13
E14	Condition:T14 Name:T15
E15	Eq-Comparison:T22 Operator:T16 Value:T19 Unit:T34 Per:T35
E16	Eq-Comparison:T23 Operator:T17 Temporal-Unit:T18 Value:T20
E1	Condition:T1 Severity:T2
E4	Assertion:T11 Asserted:E3
E9	Allergy:T26 Name:E10 Name2:E11
E10	Drug:T27 Name:T28
E11	Drug:T29 Name:T30
E17	Observation:T32 Name:T33 Numeric-Filter:E15
E18	Drug:T36 Name:T37
E19	Drug:T39 Name:T38
E20	Drug:T40 Name:T41
E21	Drug:T42 Name:T43
E22	Drug:T44 Name:T45
E24	Assertion:T47 Asserted:E25
E25	Drug:T48 Name:T49 Temporality:E16
E26	Condition:T50 
E27	Condition:T52 Name:T53
E28	Condition:T54 Name:T55
E30	Assertion:T57 Asserted:E31
E31	Drug:T58 Temporality:E32
E32	Eq-Comparison:T59 Temporal-Unit:T61 Operator:T60 Value:T21
E33	Modifier:T62 Modifies:T4
T3	Condition 69 78	infection
T4	Condition-Name 69 78	infection
T5	Life-Stage-And-Gender 25 31	Adults
T6	Condition 129 143	breast feeding
T7	Condition-Name 129 143	breast feeding
T8	Condition 116 125	Pregnancy
T9	Condition-Name 116 125	Pregnancy
T12	Condition 504 517	HIV infection
T13	Condition-Name 504 517	HIV infection
T14	Condition 519 547	systemic lupus erythematoses
T15	Condition-Name 519 547	systemic lupus erythematoses
T16	Eq-Operator 235 236	≥
T17	Eq-Operator 420 426	within
T18	Eq-Temporal-Unit 429 433	days
T19	Eq-Value 236 237	2
T20	Eq-Value 427 428	7
T21	Eq-Value 640 642	72
T22	Eq-Comparison 235 242	≥2mg/dl
T23	Eq-Comparison 420 433	within 7 days
T1	Condition 51 54	ill
T2	Severity 40 50	critically
T11	Assertion 79 89	suspection
T26	Allergy 156 163	allergy
T27	Drug 174 184	vancomycin
T28	Drug-Name 174 184	vancomycin
T29	Drug 188 201	ascorbic acid
T30	Drug-Name 188 201	ascorbic acid
T32	Observation 218 234	serum creatinine
T33	Observation-Name 218 234	serum creatinine
T34	Eq-Unit 237 239	mg
T35	Eq-Unit 240 242	dl
T36	Drug 274 290	nephrotoxic drug
T37	Drug-Name 274 290	nephrotoxic drug
T38	Drug-Name 298 313	aminoglycosides
T39	Drug 298 313	aminoglycosides
T40	Drug 315 329	amphotericin B
T41	Drug-Name 315 329	amphotericin B
T42	Drug 331 340	cisplatin
T43	Drug-Name 331 340	cisplatin
T44	Drug 344 366	calcinurine inhibitors
T45	Drug-Name 344 366	calcinurine inhibitors
T47	Assertion 374 385	Anticepated
T48	Drug 404 419	contrast medium
T49	Drug-Name 404 419	contrast medium
T50	Condition 480 488	diseases
T52	Condition 496 502	cancer
T53	Condition-Name 496 502	cancer
T54	Condition 551 571	urinary tract stones
T55	Condition-Name 551 571	urinary tract stones
T57	Assertion 579 591	Unlikelyhood
T58	Drug 615 626	medications
T59	Eq-Comparison 631 648	at least 72 hours
T60	Eq-Operator 631 639	at least
T61	Eq-Temporal-Unit 643 648	hours
T62	Modifier 64 68	MRSA
A1	Life-Stage-And-Gender-Type T5 adult
A2	Eq-Operator-Value T16 GTEQ
A3	Eq-Operator-Value T17 LTEQ
A4	Eq-Temporal-Unit-Value T18 day
A5	Severity-Value T2 severe
A6	Assertion-Type-Value E4 possible
A7	Observation-Type-Value E17 lab
A8	Assertion-Type-Value E24 hypothetical
A9	Assertion-Type-Value E30 hypothetical
A10	Eq-Operator-Value T60 LTEQ
A11	Eq-Temporal-Unit-Value T61 hour
R1	Example-Of Arg1:E19 Arg2:E18
R2	Example-Of Arg1:E20 Arg2:E18
R3	Example-Of Arg1:E21 Arg2:E18
R4	Example-Of Arg1:E22 Arg2:E18
R5	Example-Of Arg1:E27 Arg2:E26
R6	Example-Of Arg1:E12 Arg2:E26
R7	Example-Of Arg1:E14 Arg2:E26
R8	Example-Of Arg1:E28 Arg2:E26
R9	And Arg1:T5 Arg2:E1
R10	And Arg1:E1 Arg2:E3
R11	Or Arg1:E8 Arg2:E6
R12	Or Arg1:E10 Arg2:E11
R13	Or Arg1:E21 Arg2:E22
R14	Or Arg1:E14 Arg2:E28
R15	Or Arg1:E12 Arg2:E14
R16	Or Arg1:E19 Arg2:E20
R17	Or Arg1:E20 Arg2:E21
R18	Or Arg1:E27 Arg2:E12
